1. Product Overview
2.
Research Methodology
3.
Impact of COVID-19 on United Kingdom Over-The-Counter
(OTC) Drugs Market
4. Executive Summary
5. Voice of Customers
6. United Kingdom
Over-The-Counter (OTC) Drugs Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product (Cough,
Cold and Flu; Vitamins, Mineral, and Supplements (VMS); Analgesics;
Gastrointestinal Products; Dermatology Products; Others)
6.2.2. By Route of
Administration (Oral, Topical, Parenteral)
6.2.3. By Dosage Form
(Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
6.2.4. By Distribution
Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. United Kingdom
Cough, Cold and Flu Over-The-Counter (OTC) Drugs Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Route of
Administration
7.2.2. By Dosage Form
7.2.3. By Distribution
Channel
8. United Kingdom
Vitamins, Mineral and Supplements (VMS) Over-The-Counter (OTC) Drugs Market
Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Route of
Administration
8.2.2. By Dosage Form
8.2.3. By Distribution
Channel
9. United Kingdom
Analgesics Over-The-Counter (OTC) Drugs Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Route of
Administration
9.2.2. By Dosage Form
9.2.3. By Distribution
Channel
10. United Kingdom
Gastrointestinal Over-The-Counter (OTC) Drugs Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Route of
Administration
10.2.2. By Dosage Form
10.2.3. By Distribution
Channel
11. United Kingdom
Dermatology Over-The-Counter (OTC) Drugs Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Route of
Administration
11.2.2. By Dosage Form
11.2.3. By Distribution
Channel
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Policy &
Regulatory Landscape
15. United Kingdom
Economic Profile
16. Competitive
Landscape
16.1.
GlaxoSmithKline Plc.
16.2.
Novartis UK Limited
16.3.
Sun Pharmaceuticals UK Limited
16.4.
Johnson & Johnson Limited
16.5.
Perrigo Company Plc.
16.6.
Reckitt Benckiser Plc.
16.7.
AstraZeneca Plc.
17. Strategic
Recommendations
(Note: The
companies list can be customized based on the client requirements.)